Cornell Cancer & Oncology Research
80 recent oncology and cancer research papers authored by Cornell University faculty and affiliates, drawn from arXiv, newest first.
-
Practical Guide to Address Common Myths in the Pre- and Post-kidney Transplant Management of the Elderly Patient with Cancer: An Opinion Paper.2026-06-01Darshana M Dadhania
-
Active endothelial and neural regulation of valve biology, health, and disease2026-05-29G Janani, Kayla Nguyen, Jonathan T. Butcher
-
CD4 T-cell reconstitution and CD4:CD8 inversion following lymphodepleting chemotherapy for tumor-infiltrating lymphocyte therapy in metastatic melanoma.2026-05-28Barbara T. Ma
-
Real-world safety of adoptive cellular therapy with lifileucel in patients with advanced melanoma.2026-05-28Barbara T. Ma
-
Pre-diagnostic imaging and radiology report–based risk modeling for pancreatic ductal adenocarcinoma.2026-05-28Hexin Dong, Yifan Peng, G L Shih
-
A phase Ia/Ib trial of FAP-Dox (AVA6000), a fibroblast activation protein (FAP)–released doxorubicin peptide drug conjugate in patients with FAP-positive solid tumors and activity against salivary gland cancers.2026-05-28W. Tap
-
Activity of NP-G2-044 (fascin inhibitor) + anti–PD-1 in ICI-resistant advanced/metastatic solid tumors with expansion in cutaneous squamous cell carcinoma (CSCC).2026-05-28Xin‐Yun Huang
-
Anti–PD-(L)1 plus chemotherapy in advanced PD-L1–negative nonsquamous non–small cell lung cancer: A systematic review and meta-analysis.2026-05-28Alexander E. Drilon
-
Comparative analysis of national cancer policy among low-income, low-middle-income, and high-middle-income countries.2026-05-28Syeda Akila Ally
-
SARC045: A phase 2 trial of tebentafusp in HLA-A*02:01–positive patients with advanced clear cell sarcoma.2026-05-28Sandra P. D'Angelo
-
Tumor evolution following treatment with sacituzumab govitecan for metastatic breast cancer: A proteomic analysis.2026-05-28Komal L. Jhaveri
-
Monitoring PD-L1 expression in circulating cancer associated cells for prediction of clinical outcomes in metastatic breast cancer patients treated with immune checkpoint inhibitors.2026-05-28M Cristofanilli, Carolina Reduzzi
-
Liquid biopsy to stratify metastatic breast cancer progression risk using multi-analyte cell subtyping prior to systemic therapy.2026-05-28M Cristofanilli, Carolina Reduzzi
-
Stratifying survival benefit of encorafenib/cetuximab (EC) in BRAF V600E–mutant mCRC using clinical and inflammatory biomarkers: Real-world experience from greater Manchester.2026-05-28Panagiotis J. Vlachostergios
-
Safety and efficacy of daraxonrasib monotherapy as later-line (3L+) treatment for patients (pts) with metastatic pancreatic adenocarcinoma (PDAC).2026-05-28Wungki Park
-
TREGCHECK 102: A study of tagmokitug (CHS-114) in combination with toripalimab and/or other treatments in participants with advanced solid tumors.2026-05-28Yelena Y. Janjigian
-
Comprehensive genomic profiling of patients with cancer of unknown primary (CUP).2026-05-28Panagiotis J. Vlachostergios
-
<i>MACROD2</i> and <i>CDKN2A</i> in multiple myeloma: Insights to germline susceptibility and cytogenetic risk from long-read Nanopore sequencing.2026-05-28Rohan Sarkar
-
Immune-mediated toxicities (irAEs) in immune checkpoint inhibitor (ICI) therapy in various combinations: A real-world sample.2026-05-28Neil J. Shah
-
Don’t ask, don’t tell: Missing ECOGS and anticancer treatment, neutrophil-to-lymphocyte ratios, and outcomes in hospitalized patients with solid tumors.2026-05-28Holly G. Prigerson, Christine A. Garcia, Ann Rosen, Lindsay Lief, David Berlin, Silvia C. Formenti, Rutika Mehta, Rachel Ann Oshins, Julia Rebecca Sobel, Madiso
-
Randomized multicenter phase II trial of radioimmunotherapy versus chemoimmunotherapy followed by surgery for c-stage IB-III NSCLC (RICHIS trial).2026-05-28Jonathan Villena-Vargas, Jeffrey L. Port, Dan Jones, Oliver S. Chow, S. Harrison, Benjamin E. Lee, Christine A. Garcia, Ashish Saxena, Nicholas J Sanfilippo, D.
-
Efficacy prediction for progression-free survival (PFS) and overall survival (OS) by genomic instability score (GIS) cutoffs in patients (pts) with advanced ovarian cancer (aOC): Post hoc results from the phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial.2026-05-27Roisin Eilish O'Cearbhaill
-
Immune priming with the EZH2 inhibitor tazemetostat in B-cell lymphomas receiving CAR T-cell therapy.2026-05-27Samuel Yamshon, Caitlin Gribbin, Yusuke Isshiki, Ioannis Karagiannidis, Sunjae Lee, Jizhi Yan, Gwynne Ozkan, Anna Alperovich, Barbara T. Ma, Christopher Hackett
-
Format matters: Digital vs print delivery of a job retention intervention during breast cancer therapy.2026-05-27Shoshana M. Rosenberg
-
KEYNOTE-811: 6-year median follow-up of pembrolizumab plus trastuzumab and chemotherapy for previously untreated advanced HER2-positive gastric or gastroesophageal junction adenocarcinoma.2026-05-27Yelena Y. Janjigian
-
Oncologic outcomes following biologic therapy for immune-related cutaneous adverse events.2026-05-27Michael A. Postow, Neil J. Shah
-
Survivorship-focused content at the American Society of Clinical Oncology (ASCO) 2022-2024 annual meetings.2026-05-27Christine A. Garcia
-
Effect of a weight loss intervention (WLI) on quality of life (QOL) and symptoms in women with breast cancer: Results from the Breast Cancer Weight Loss (BWEL) trial.2026-05-27Vered Stearns
-
Association of the 70-gene assay and homologous recombination deficiency in patients with high risk 2 breast cancers.2026-05-27M Cristofanilli
-
Results from a phase 2a study of atebimetinib in combination with mGnP in advanced or metastatic pancreatic cancer.2026-05-27Anna C. Pavlick, Allyson J. Ocean, Barbara T. Ma
-
Efficacy and circulating protein biomarkers of second-line aflibercept plus FOLFIRI according to prior bevacizumab or cetuximab treatment in advanced colorectal cancer (KCSG CO21-21).2026-05-27Colin Burdette, Jacob B. Geri
-
Long-term safety outcomes of pregnancy among young breast cancer survivors: Results from a prospective, multicenter cohort study.2026-05-27Shoshana M. Rosenberg, Rulla Tamimi
-
HER2-independent antitumor and pharmacodynamic responses to trastuzumab deruxtecan in patients with advanced solid tumors.2026-05-27Cora N. Sternberg
-
Phase 2 multicenter trial of chemoimmunotherapy for patients with neuroendocrine or aggressive variant metastatic prostate cancer (CHAMP).2026-05-27David M. Nanus, Cora N. Sternberg
-
Associations of oral contraceptives with expression of CD44, CD24, and ALDH1A1 stem cell markers in women with benign breast biopsies2026-05-27Rulla M. Tamimi
-
Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers2026-05-21Shari B. Goldfarb, Benjamin D. Greenbaum
-
Comparison of early-onset and average-onset colorectal cancer in Saudi Arabia: A multicenter retrospective cohort study2026-05-19S A Alqahtani
-
First-in-class small molecule ROBO2 binders identified through integrated virtual screening and biophysical validation2026-05-19Kirti Upmanyu, Hossam Nada, Moustafa T. Gabr
-
A National Survey-Based Study of Factors Influencing Dermatologists Performing Nail Biopsies2026-05-18Rachel C. Hill, Shari R. Lipner
-
Cellular stemness identifies high-risk ductal carcinoma in situ and offers a therapeutic interception opportunity2026-05-16Mahinur Mattohti
-
Tie2 inhibition disrupts TMEM doorway function and reduces dissemination in pancreatic ductal adenocarcinoma2026-05-16Nicole C. Panarelli
-
Preoperative hypoalbuminemia and survival among patients selected for primary cytoreduction in advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary study2026-05-15Vance Broach, K. Long, Ginger J. Gardner, Yukio Sonoda, Nadeem R. Abu-Rustum, Dennis S. Chi
-
A multi-omic, spatial, and whole-slide image dataset of lung neuroendocrine tumours from the lungNENomics cohort2026-05-14Z Li, Jaehee Kim
-
Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer2026-05-14Shoshana M Rosenberg, Laura C. Collins
-
Optimizing Breast Cancer Survivorship: Addressing Lifestyle, Weight Management, and Psychological Health2026-05-13Jane Chen
-
Pancreatic MRI Findings in High-Risk Individuals Compared with Matched Average-Risk Individuals2026-05-11J Faiz, Xiaohong Jin
-
Dimensionality Impacts Effect Of Estradiol On Breast Cancer Cell Behavior2026-05-09Matthew Liao, Samuel Medina, Olivia Carrafiell, Gabrielle Kupferman, Paul Kim, Steven Danilav-Lee, Xue Dong, Jason Spector
-
Advancing Skin-tone Equity In Contactless Flap And Graft Monitoring: A Scoping Review And The Ster-8 Checklist2026-05-09Joclin Rabinovich
-
Dimensionality Impacts Effect Of Estradiol On Breast Cancer Cell Behavior2026-05-09Matthew Liao, Samuel J. Medina, Olivia H. Carrafiell, Gabrielle S. Kupferman, Paul K. Kim, Steven Danilav-Lee, Xue Dong, Jason A. Spector
-
Association between prostate cancer and mental health: a comparison across cancer types using the medical expenditure panel survey, 2017–20222026-05-07Jaeuk Shin
-
Pancreatic cancer2026-05-07Eileen M. O´Reilly
-
Advancing Skin-tone Equity In Contactless Flap And Graft Monitoring: A Scoping Review And The Ster-8 Checklist2026-05-07Samantha Rabinovich, Derrick Lin, Sumun Khetpal, Kassra Garoosi, Ainaz Dory Barkhordarzadeh, Eliana Jolkovsky
-
Photoreactivity of Ru <sup>2+</sup> Polypyridyl Complexes Bearing the H <sub>2</sub> S-Releasing Compound GYY41372026-05-07Piyusha S. Lotlikar, Valerie Chang, Joshua J. Woods, Nicholas P. Bigham, Justin J. Wilson
-
Advancing Skin-tone Equity In Contactless Flap And Graft Monitoring: A Scoping Review And The Ster-8 Checklist2026-05-07Samantha Rabinovich, Derrick Lin, Sumun Khetpal, Kassra Garoosi, Ainaz Dory Barkhordarzadeh, Eliana Jolkovsky
-
Access to CAR-T therapy in Latin America: Barriers, gaps, and pathways forward2026-05-05Jorge Contreras, Lauren Herschbein, Nimisha Mathur, Monica L. Guzman
-
Beyond Diagnosis: Survivorship Research for People Living with Advanced and Metastatic Cancers.2026-05-01Emily S Tonorezos
-
Disrupted molecular glue complex drives RAS inhibitor resistance2026-05-01Diego J. Rodriguez, Rona Yaeger, Kathryn C. Arbour, Piro Lito
-
Third-Party Viral Specific T cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCT2026-05-01Parastoo B. Dahi
-
Real-World, Evidence-Based, Retrospective Study of Patients Infused with Commercially Released Lifileucel for Advanced Melanoma2026-05-01Barbara T Ma, Kimberly Loo, James W. Smithy, Anna C. Pavlick, Alexander N. Shoushtari
-
Phase 2 study of talabostat, a small molecule inhibitor of dipeptidyl peptidases (DPP), administered in combination with pembrolizumab in patients with small cell neuroendocrine prostate cancer2026-05-01Scott Tagawa
-
Tumor immune microenvironment reconstitution in patient-derived organoids enables therapy modeling for NSCLC2026-05-01Enrique Podaza, Jared Capuano, Hui–Hsuan Kuo, Majd Al Assaad, Geoffrey Markowitz, M. Victoria Revuelta, John Nguyen, Adriana Irizarry, Hiranmayi Ravichandran, S
-
An ICAM1-targeting chimeric costimulatory receptor mimics the immune synapse and enhances tumor-specific T cell function2026-04-27Yanping Yang, Dessislava Stefanova, Yago Alcaina, Maria Cristina Riascos, Kevin J. Chen, Juan González‐Valdivieso, Maneeza Bilal, Bing He, Rasa Zarnegar, Thomas
-
Tumor cell intrinsic mechanisms of immune escape2026-04-25Robert Glassman
-
Structural basis for ADAM17 activation by the iRhom1 pseudoprotease2026-04-22Carl Blobel
-
LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in <i>LKB1</i> -Mutant Lung Cancer2026-04-20Alberto M. Herrera
-
Genetically driven immune microenvironment states associate with therapeutic responses in MYD88 mutant lymphomas2026-04-20Maria V. Revuelta, Leandro Cerchietti
-
Abstract CT209: DiscovHER PAN-206: Phase 2 tumor-agnostic study of zanidatamab in patients with previously treated human epidermal growth factor receptor 2-overexpressing solid tumors2026-04-17Vicky Makker
-
BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings2026-04-16James J. Harding
-
Chimeric antigen receptor T cells for autoimmune diseases, in particular immune thrombocytopenia2026-04-16Samuel Soff, Samuel Ruder, James B. Bussel
-
Bleeding and thrombosis in patients receiving chimeric antigen receptor T-cell therapy2026-04-16Avi Leader
-
The Impact of BK Viremia on Donor-Derived Cell Free DNA and Gene Expression Profiling Scores in Heart Transplant Recipients2026-04-16D. Majure
-
Incidence of Post-Transplant Malignancy in Simultaneous Multiorgan (Heart-Lung, Heart-Liver, Heart-Kidney) Recipients Compared with Single-Organ Heart Transplant Recipients: A Single Center Experience2026-04-16M. Regan, D. Majure
-
Multiplex organoid mutagenesis reveals gene combinations driving transformation, pathology and chemosensitivity in ovarian carcinoma2026-04-15Daryl J. Phuong, Coulter Q. Ralston, Tamer Ezzat, Christopher S. Ashe, Amanda P. Armstrong, Andrea Flesken-Nikitin, Robert J. Yamulla, A Y Nikitin, John C. Schi
-
Barriers to Health Care and Cancer Screening2026-04-14Aaron Gurayah, Anjile An, Manish Kuchakulla, Faith Morley, Daniel Markowitz, Jialin Mao, Meenakshi Davuluri, Bashir Al Hussein Al Awamlh, David M. Nanus, Rulla
-
Modifying Epigenetic Landscapes to Restore Immune Therapeutic Responses in Triple Negative Breast Cancer2026-04-12Nigel P. Mongan
-
Pancreatic Cancer—Advances in the Last 50 Years2026-04-11Eileen M. O'Reilly
-
Remote Symptom Assessment in Ambulatory Palliative Care: User-Centered Development of an mHealth App2026-04-10Emily Bivona-Maldonado, Zilong Yu, Maureen Ekwebelem, Samprit Banerjee, M. Carrington Reid, Daniel Shalev
-
Author Correction: Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function2026-04-08Costas A. Lyssiotis, Lewis C. Cantley
-
Preoperative Biliary Drainage with Metal Stent Versus Early Surgery in Patients with Pancreatic Cancer: A Randomized Clinical Trial2026-04-08David L. Carr-Locke, Rohit Chandwani
-
EBV Triggers a Distinct Antiviral Response in HMC3 Cells2026-04-07Anuj Ahuja, Miranda McGaskey, Ethel Cesarman